Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

31 Mar 2026 07:00

RNS Number : 5254Y
Ebiquity PLC
31 March 2026
 

31 March 2026

Ebiquity Plc

("the Company" or "Ebiquity")

 

Total Voting Rights

 

Ebiquity plc, the independent authority in marketing effectiveness, notifies that, as of 31 March 2026, the Company's share capital consists of 141,215,531 ordinary shares of 25 pence each ("Ordinary Shares"), with each Ordinary Share carrying the right to one vote.

 

The Ebiquity plc Employee Benefit Trust holds 2,262,845 Ordinary Shares to satisfy awards under the Company's share option plans. The trustee of the EBT has agreed not to vote Ordinary Shares held by it such that these Ordinary Shares are treated as not carrying voting rights.

 

The total voting rights in the Company are therefore 138,952,686. This figure may be used by shareholders as the denominator for calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Ebiquity plc

Dorcas Murray, Company Secretary

 +44 (0) 20 7650 9600

 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson/ Andrea Callaghan - Corporate Finance

 +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

 

About Ebiquity plc

 

Ebiquity is the independent authority in Marketing Effectiveness. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by over 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

For further information, please visit: www.ebiquity.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUBSBRNKUOUAR
Date   Source Headline
25th Mar 20217:00 amRNSFinal Results
12th Mar 20217:00 amRNSAppointment of Nominated Adviser and Broker
15th Feb 20217:00 amRNSPre-close Trading Update
4th Jan 20218:00 amRNSTotal Voting Rights
8th Dec 20204:00 pmRNSIssue of Shares
25th Nov 202010:30 amRNSDirector/PDMR Shareholding
18th Nov 20208:00 amEQSEbiquity (EBQ): Digital acceleration
10th Nov 20207:00 amRNSCapital Markets Day
30th Oct 20203:55 pmRNSHolding(s) in Company
24th Sep 20207:00 amRNSInterim Results
25th Aug 20208:00 amRNSNotification of Interim Results
26th Jun 202012:20 pmRNSAGM resolutions passed
12th Jun 20204:30 pmRNSNotice of AGM correction
3rd Jun 20207:00 amRNSTotal Voting Rights
29th May 20209:30 amRNSNotice of AGM and Annual Report
28th May 20203:30 pmRNSCompletion of acquisition and issue of shares
21st May 20203:50 pmRNSDirector/PDMR Shareholding
20th May 20204:00 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSFinal Results
18th May 202010:15 amRNSNotification of Preliminary Results
14th May 20204:15 pmRNSHolding(s) in Company
22nd Apr 20207:00 amRNSDirectorate Change and update on Covid-19 impact
24th Mar 20207:00 amRNSPostponement of Results and COVID 19 update
10th Mar 20202:55 pmRNSHolding(s) in Company
28th Feb 20202:05 pmRNSHolding(s) in Company
26th Feb 20205:30 pmRNSHolding(s) in Company
26th Feb 20205:11 pmRNSCorrection - Total Voting Rights
24th Feb 202012:05 pmRNSHolding(s) in Company
24th Feb 202012:00 pmRNSHolding(s) in Company
21st Feb 20204:00 pmRNSHolding(s) in Company
21st Feb 20208:45 amRNSHolding(s) in Company
19th Feb 20207:00 amRNSPre-close Trading Update
3rd Feb 20207:00 amRNSTotal Voting Rights
3rd Feb 20207:00 amRNSAcquisition of minority interest in subsidiary
31st Jan 20203:00 pmRNSIssue of Shares
8th Jan 20207:00 amRNSEbiquity acquires Digital Decisions B.V.
2nd Jan 20207:00 amRNSHolding(s) in Company
5th Dec 20197:00 amRNSDirector/PDMR Shareholding
12th Nov 20193:00 pmRNSDirectorate Change
1st Nov 20197:00 amRNSTotal Voting Rights
16th Oct 20199:50 amRNSIssue of Shares
14th Oct 201912:15 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSDirector/PDMR Shareholding
2nd Oct 20199:15 amRNSNotification of Capital Markets Day
1st Oct 20197:00 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSInterim Results
21st Aug 20199:40 amRNSHolding(s) in Company
19th Aug 20192:50 pmRNSHolding(s) in Company
19th Aug 201910:05 amRNSNotice of Interim Results
4th Jun 20192:25 pmRNSAGM resolutions passed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.